Janssen Biotech, Inc v. The United States of America > Summary
Court Case Number IPR2021-01484
Filing Date Sep 9, 2021
Institution Decision Date Mar 2, 2022
Decision Date Mar 2, 2022
Court Patent Trial and Appeal Board
Status Terminated-Denied
Administrative JudgesRobert A. Pollock, Sheridan K. Snedden, Devon J. Zastrow Newman
Judge Writing the Final DecisionRobert A. Pollock
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 13, 17, 19
Petitioner
Patent Owner
4Petitioner Attorneys
3Janssen Biotech, Inc.
Attorney Name: David P. Frazier
Latham & Watkins
Janssen Biotech, Inc.
Attorney Name: Michael A. Morin
Latham & Watkins
Janssen Biotech, Inc.
Attorney Name: Michael R. Seringhaus
Latham & Watkins
Patent Owner Attorneys
4Related Patents
Doc No | Title | Issue date |
---|---|---|
09765342 | Chimeric antigen receptors targeting B-cell maturation antigen | Sep 19, 2017 |